Collaboration will focus on the development of smart neurostimulators for the treatment of severe chronic diseases More: Merck partners with Innervia on bioelectronic therapy development Source: News
read moreCOVID-19 infection rates were three times lower in fully vaccinated people compared to unvaccinated people More: Study finds lower COVID-19 infection prevalence in fully vaccinated people Source: News
read morePriority review comes following positive results from the Phase III NAVIGATOR trial More: AZ, Amgen’s asthma med tezepelumab gains FDA priority review Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals